JOHNSON & JOHNSON — Director's Dealing 2025

Nov 14, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVRx, Inc. (CVRX)
CIK: 0001235912
Period of Report: 2025-11-12

Reporting Person: JOHNSON & JOHNSON (N/A)
Reporting Person: Johnson & Johnson Innovation - JJDC, Inc. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-12	Common Stock	S	1000	$10.00	Disposed	4049898	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. 29 shares were sold at $10.04 and 971 shares were sold at $10.00.

F2: The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.